Professor HO Chi Lui, Paul

BSc(Pharm) (Hons), PhD, University of Queensland, Australia
Post-doctoral study (clinical Pharmacology), University of Michigan, Ann Arbor, USA.

Department of Pharmacy, National University of Singapore
18 Science Drive 4, Singapore 117543
Tel: +65 6516 2651
Fax: +65 6779 1554

Teaching Activities in NUS

  • PR1105 Pharmacy Practice I
  • PR2101 Pharmaceutical Biotechnology
  • PR2106/4102 Pharmacy Practice II
  • PR4213 Research Methodology

Research Interests

Pharmacokinetics (PK) is the study of drug absorption, distribution, metabolism and elimination (ADME). Inappropriate PK characteristics often caused failure in the later clinical phases in the development of a new pharmaceutical compound.


Early screens for desired PK properties are increasingly being employed in the selection of new chemical entities (NCE) for drug development. A new chemical entity will rarely enter further drug development without some information regarding its metabolism and PK properties.


Our research focus is on pharmacokinetics and biopharmaceutics of anticancer agents. Currently, We are actively engaged in the studies of retinoids in the treatment of leukemia and arsenic compounds in the treatment of gynecological cancers.